Phenotype | None |
Sample Ancestry | European |
Total number | 8,752 individuals |
Detailed numbers |
703 cases (8.03%)
8,049 controls
0.0% Male samples
|
Number of Cohort(s) | 59 |
Cohort Short Name | Cohort Full Name | Previous/other/additional names (e.g. sub-cohorts) |
---|---|---|
BCFR-AU | Breast Cancer Family Registry Australia | — |
BCFR-NY | New York Breast Cancer Family Registry | — |
BCFR-PA | Philadelphia Breast Cancer Family Registry | — |
BCFR-UTAH | Utah Breast Cancer Family Registry | — |
BFBOCC | Baltic Familial Breast and Ovarian Cancer Consortium | — |
BMBSA | BRCA-gene mutations and Breast Cancer in South African Women | — |
BRICOH | Beckman Research Institute of the City of Hope | — |
CNIO | Spanish National Cancer Centre | — |
COH | City of Hope Cancer Centre | — |
CONSIT_TEAM | CONsorzio Studi ITaliani sui Tumori Ereditari Alla Mammella | CONSIT TEAM |
CopBCS | Copenhagen Breast Cancer Study | — |
DEMOKRITOS | Hellenic Cooperative Oncology Group | — |
DFCI | Harvard Breast Cancer SPORE Blood Repository | — |
DKFZ | Deutsches Krebsforschungszentrum (German Cancer Research Center) | — |
EMBRACE | Epidemiological study of BRCA1 and BRCA2 mutation carriers | — |
FCCC | Fox Chase Cancer Center | — |
GC-HBOC | German Consortium for Hereditary Breast & Ovarian Cancer | — |
GEMO | Genetic Modifiers of cancer risk in BRCA1/2 mutation carriers | — |
Georgetown | Georgetown | — |
G-FaST | G-FaST | — |
HCSC | Hospital Clinico San Carlos | — |
HEBCS | Helsinki Breast Cancer Study | — |
HEBON | Hereditary Breast and Ovarian Study Netherlands | — |
HUNBOCS | Molecular Genetic Studies of Breast and Ovarian Cancer in Hungary | — |
HUVH | Hospital Universitari Vall dHebron | — |
ICO | Institut Català d'Oncologia | — |
IHCC | International Hereditary Cancer Centre | — |
INHERIT | Interdisciplinary Health Research Internal Team Breast Cancer Susceptiblity | — |
IOVHBOCS | Instituto Oncologico Veneto Hereditary Breast and Ovarian Cancer Study | — |
IPOBCS | Portuguese Oncology Institute-Porto Breast Cancer Study | — |
kConFab | Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer | — |
KUMC | University of Kansas Medical Centre | — |
LUHR | Landspitali University Hospital, Reykjavik | — |
MACBRCA | The Ohio State University Comprehensive Cancer Centre | — |
MAYO | The Mayo Clinic study | MAYO clinic biobank |
MCGILL | McGill University | — |
MDACCS | MD Anderson Cancer Center Study | — |
MODSQUAD | Modifier Study of Quantitative Effects on Disease | — |
MSKCC | Memorial Sloan Kettering Cancer Center | — |
MUV | Medical University of Vienna | — |
NC-BCFR | Northern California Breast Cancer Family Registry | — |
NCI | National Cancer Institute | — |
NICCC | National Israeli Cancer Control Center | — |
NNPIO | N.N. Petrov Institute of Oncology | — |
NRG_ONCOLOGY | NRG Oncology | — |
NSUHS | North Shore University Health System | — |
OCGN | Ontario Cancer Genetics Network | — |
OFBCR | Ontario Familial Breast Cancer Registry | — |
OUH | Odense University Hospital | — |
PiBCS | Pisa Breast Cancer Study | — |
SWE-BRCA | Swedish Breast Cancer Study | SWEBCS |
UC | University of Chicago | — |
UCLA | UCLA ATLAS Community Health Initiative | — |
UCSF | University of California, San Francisco | — |
UKGRFOCR | UK and Gilda Radner Familial Ovarian Cancer Registries | — |
UPENN | University of Pennsylvania | — |
UPITT | Cancer Family Registry, University of Pittsburg | — |
VFCTG | Victorian Familial Cancer Trials Group | — |
WCRI | Womens Cancer Research Institute - Cedars-Sinai Medical Center | — |